HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Industry Group Poised for Pilot Rollout of E-Labeling App in April, Looks to Sales Reps for Popularization
March 26, 2021
-
BUSINESS Astellas Sees Growth Potential for “Rx+” as Future Bread-and-Butter Biz: EVP
March 26, 2021
-
REGULATORY Chuikyo OKs Appraisal Results for Kymriah, Trelegy; Downward Price Tweaks Expected
March 25, 2021
-
REGULATORY Nichi-Iko Plant Probed before Lifting of Biz Suspension Order
March 25, 2021
-
REGULATORY Japan Approves Incyte’s Pemazyre, Bayer’s Vitrakvi, Novartis’ Kesimpta, and More
March 24, 2021
-
REGULATORY Appraisal Results for Kymriah, Trelegy Up for Chuikyo Review on March 24; Price Cuts Likely
March 23, 2021
-
BUSINESS Japan Approves 3rd CAR-T Cell Therapy, Celgene’s Breyanzi
March 23, 2021
-
ORGANIZATION Japan Govt Should Change Course on Consistent Price Cuts for On-Patent Drugs: FPMAJ Exec
March 22, 2021
-
BUSINESS Takeda’s OTC Unit to Be Renamed Alinamin with New Chief from Blackstone
March 22, 2021
-
REGULATORY MHLW to Set Up Medical Supply Office in April after COVID-19, Antibiotic Shortage
March 19, 2021
-
ORGANIZATION Trade Groups Push Proper Pricing of Innovative Drugs to Restore Attractiveness of Japan: LDP Confab
March 19, 2021
-
ORGANIZATION With Aducanumab in Mind, Outgoing Chuikyo Payer Rep Floats Rule to Reward Cost Cuts for Pricey Meds
March 18, 2021
-
BUSINESS Morimoto Pharma Looking to Partner with Drug Makers, CMOs to Develop Freeze-Dried COVID Vaccines in Japan
March 17, 2021
-
BUSINESS Quake-Halted Nipro Plant Affecting Supplies of Pfizer, Espha Generics
March 17, 2021
-
BUSINESS Alesion Dry Syrup, Generics Pulled from Shelves over Mutagenic Impurities
March 16, 2021
-
BUSINESS Takeda Appoints Milano Furuta as New Japan Chief
March 16, 2021
-
ACADEMIA Tokushukai Weighs Switches from Nichi-Iko Products after Biz Suspension Order
March 15, 2021
-
BUSINESS Me Pharma Eyes Production of 1 Billion Tablets in FY2021, Sales Buoyed by Low Prices
March 12, 2021
-
BUSINESS JMA Affiliate Data Operator Poised to Provide RWD from NHO Hospitals to Drug Makers
March 11, 2021
-
BUSINESS Takeda to Buy Out T-Cell Engager Specialist Maverick for US$525 Million
March 11, 2021
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
